CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.

CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease. Gastroenterology. 2022 10; 163(4):950-964.

View in: PubMed

subject areas

Biomarkers
Chronic Disease
Colitis, Ulcerative
Consensus
C-Reactive Protein
Crohn Disease
Humans
Inflammatory Bowel Diseases
Leukocyte L1 Antigen Complex
Quality of Life
Randomized Controlled Trials as Topic

authors with profiles

David T. Rubin
Stephen B. Hanauer